Ufp Technologies Stock Price, News & Analysis

UFP Technologies, Inc. (Nasdaq: UFPT) reported significant financial growth in its Q3 2022 results. Net income surged to $19.5 million ($2.56 per diluted share), up from $3.8 million ($0.50 per share) in Q3 2021. Sales increased by 91% to $97 million, driven primarily by the medical market, which saw a 152% increase. Year-to-date sales reached $262.6 million, a 75% increase from the previous year. Notably, gross margins improved to 26.3%, up 260 basis points from the prior year.

UFP Technologies (Nasdaq: UFPT), a custom manufacturer for the medical market, will present at the Sidoti September Small-Cap Virtual Conference on September 21, 2022, at 10:00 am ET. The presentation can be accessed live at Sidoti's website and the company's investor relations page here. Additionally, UFP Technologies will host virtual one-on-one meetings with investors on the same day. Registration is free.

UFP Technologies (UFPT) reported strong Q2 2022 results with a net income of $8.9 million, or $1.17 per diluted share, compared to $4.7 million in Q2 2021. Sales surged 86.2% to $94.3 million, driven by 17.9% organic growth and contributions from recent acquisitions. Operating income increased 97% to $12.2 million. However, gross margins decreased to 25.8%. The company also sold its Molded Fiber business for $32 million to concentrate on its MedTech sector. Year-to-date sales reached $165.6 million, up 66.8% from 2021.

UFP Technologies, Inc. (Nasdaq: UFPT) announced the sale of its molded fiber business, Moulded Fibre Technology, Inc. (MFT), to CKF, Inc. for approximately $32 million. This strategic divestiture is aimed at reallocating resources to enhance its MedTech segment, which now constitutes 82% of UFP's revenue. MFT, acquired in 1993, reported an annual revenue of $21.3 million in 2021. The sale is expected to provide synergies for MFT under CKF, focusing on molded fiber products, while UFP pursues growth opportunities in the medical market.

UFP Technologies (Nasdaq: UFPT) has opened a new medical manufacturing facility in Tijuana, Mexico. This 84,000-square-foot, FDA-registered plant will specialize in clean room and clean space manufacturing for medical devices. CEO R. Jeffrey Bailly highlighted Tijuana's strategic location near customers and its reputation in medical device production as key factors for the move. UFP Technologies is recognized for its innovation in designing and manufacturing components and packaging primarily for the medical sector.

UFP Technologies, Inc. (UFPT) will participate in the virtual East Coast IDEAS Investor Conference on June 22-23, 2022. The presentation by R. Jeffrey Bailly, CEO, and Ron Lataille, CFO, is scheduled for 6:00 am ET on June 22. It will be available on the conference site and can also be accessed via the host’s website and UFP Technologies' investor relations page. IDEAS Conferences connect quality companies with investment professionals, emphasizing regional investment communities.

UFP Technologies, Inc. (Nasdaq: UFPT) announced participation in the Sidoti Fall Virtual Investor Conference on June 15-16, 2022, featuring CEO R. Jeffrey Bailly and CFO Ron Lataille. The live presentation is scheduled for June 16 at 10:00 A.M. ET and can be accessed online. UFP Technologies specializes in designing and converting foams, plastics, and natural fibers for the medical market, and also serves aerospace, automotive, and industrial sectors. Registration for the event is free, and one-on-one investor meetings are available on the same day.

UFP Technologies, Inc. (Nasdaq: UFPT) reported a strong Q1 2022, with net income rising to $4.9 million ($0.64 per diluted share), up from $4.2 million ($0.55 per diluted share) a year prior. Sales surged 46.6% to $71.2 million, driven largely by 75.1% growth in the medical market. Despite $775,000 in one-time acquisition costs and ongoing supply chain challenges affecting gross margins, operating income increased to $6.4 million. The company also completed key acquisitions and a new manufacturing facility in Tijuana, positioning itself for future growth.

UFP Technologies, Inc. (Nasdaq: UFPT) announced the acquisition of Advant Medical Ltd., enhancing its capabilities in medical device manufacturing. Advant Medical, based in Ireland, specializes in Class I, II, and III medical devices and brings in-house injection molding expertise. This acquisition is UFP's third in six months and aims to strengthen its position in the catheter and guidewire packaging market. The deal will foster new customer relationships and product development opportunities while leveraging UFP’s engineering capabilities.